| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 46.56B | 44.55B | 40.98B | 41.95B | 41.68B | 41.17B |
| Gross Profit | 36.58B | 34.77B | 32.43B | 33.17B | 31.88B | 29.91B |
| EBITDA | 21.73B | 20.61B | 19.63B | 21.27B | 19.19B | 16.93B |
| Net Income | 13.05B | 12.33B | 11.64B | 13.40B | 12.16B | 10.96B |
Balance Sheet | ||||||
| Total Assets | 127.76B | 121.05B | 109.11B | 99.47B | 86.23B | 75.40B |
| Cash, Cash Equivalents and Short-Term Investments | 105.53B | 100.57B | 89.85B | 80.14B | 67.15B | 56.01B |
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 19.50B | 16.02B | 15.10B | 15.79B | 14.93B | 14.33B |
| Stockholders Equity | 108.25B | 105.03B | 94.00B | 83.68B | 71.30B | 61.07B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 14.98B | 13.03B | 16.80B | 14.06B | 12.97B |
| Operating Cash Flow | 0.00 | 15.02B | 13.05B | 16.80B | 14.08B | 12.99B |
| Investing Cash Flow | 0.00 | -27.13B | -8.56B | -3.85B | -2.02B | -3.82B |
| Financing Cash Flow | 0.00 | -1.28B | -1.28B | -1.03B | -1.03B | -641.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥32.19B | 19.37 | ― | 1.74% | 21.97% | 15.89% | |
69 Neutral | ¥234.74B | 21.08 | ― | 0.43% | 15.01% | 19.66% | |
68 Neutral | ¥22.29B | 9.96 | ― | ― | 17.93% | 91.21% | |
68 Neutral | ¥31.62B | 27.58 | ― | 0.39% | 30.59% | 65.14% | |
65 Neutral | ¥14.17B | 25.11 | ― | 0.91% | 15.28% | 60.07% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
52 Neutral | ¥132.93B | 367.27 | ― | 0.14% | 36.42% | 28.23% |